Mission Viejo, CA - (http://www.FinancialNewsMedia.com
News Alert) - Embark Holdings, Inc. (OTC: EMBK) a leader in providing research, evaluation and acquisition services to businesses throughout the world, announced acquiring 100% of Muscle Warfare, Inc. (http://musclewarfare.com
) a company that develops, manufactures, and markets sports nutrition products of the highest quality for athletes around the world in all sports, including both professional and amateur enthusiasts. The acquisition consisted of preferred shares in Embark Holdings, Inc.
Muscle Warfare products are certified banned substance free by the World Anti-Doping Agency ("WADA") standards and are tested in one of the most elite testing labs in the world called HFL Sport Science, the world's largest and most experienced sports test laboratory. The HFL laboratory is ISO Certified and accredited for forensic testing and meets or exceeds world anti-doping agency standards and requirements. The company's processes insure that the product offerings distributed are free of inadvertent contaminants and are not deliberately spiked with contaminant compounds by many raw material manufacturers. Additionally, all Muscle Warfare products are manufactured in facilities that are NSF International "third party audited" and certified to meet or exceed, Good Manufacturing Practice ("GMP") guidelines. GMP quality assurance also insures all raw materials used in our products 'meet spec' and are what they claim to be.
Since 2008 Muscle Warfare, Inc. has been led by Mr. Daniel Amato. For the past 13 years he has been recognized as a proven winner within the industry with many successes and proven track record marketing and branding sports nutrition products through multiple brands and marketing strategies.
Muscle Warfare has reached approximately $1.9 million in sales in 2011, however, in 2012 Muscle Warfare performed a calculated pull back of sales distribution to successfully navigate an industry wide FDA notice on the ingredient DMAA, which restricted sales industry wide. "We expected to hit 3-4 Million in sales in 2012 with strong profits. Instead, we decided to utilize this time to carefully rebrand our products to be banned substance free and create formulations that were even more effective. During this process we had intentionally slowed sales to rebrand the company, upgrade our look and presentation and take our overall quality standards to the highest level," said Mr. Amato.
Muscle Warfare is pleased with this strategy as it has worked; we are now distributing product in approximately 550+ Vitamin Shoppe stores Nationwide. Also, they have a very strong partnership with Europa, the largest independent sports nutrition distributor in the U.S.; along with many Large scale International Clients, which we believe will help continue our growth trajectory.
Year-Ended 2011 Year-Ended 2012
Net Sales $1,902,583.00 $1,613,232.00
COGS $1,044,125.00 $ 966,391.00
Operating Expenses $1,039,661.00 $1,171,105.00
Net Income ($181,203.00) ($ 524,264.00)
The Sports Nutrition Market is among the fastest growing and was one of the most resilient markets since the 2007 market downturn, experiencing impressive growth during this entire period. This strong and rapid market growth is forecasted by experts to continue for years to come due to continued and growing use and promotion of these products by elite professional athletes and bodybuilders. In addition, the amateur athlete market continues to expand and grow which is increasing the use of these products; this segment is expected to exceed $6 billion by 2018 according to the most recent Consumer Trend Reports.
Daniel Amato, President and CEO of Embark Holdings, Inc. and Muscle Warfare, Inc. stated "I am very excited about the future of both companies and will keep the public informed of the progress. In addition, I would like to inform our shareholders that we have recently subscribed to OTCIQ and within a few weeks plan to be current with OTC Markets and continue to file reports on a quarterly basis, this is a very exciting time for the company and only the beginning of what I believe will be another success story."
About Muscle Warfare, Inc.
Muscle Warfare is a cutting edge sports nutrition manufacturer that is passionately driven to create and distribute the absolute highest quality products in the marketplace. Every product we develop has been forged with great experience and focus on maximizing product efficacy for real world results. Furthermore, Muscle Warfare products are rigorously tested by top testing labs to help insure them free of banned substances. We are truly committed to helping all athletes achieve and surpass their highest goals and potential.
For more information on Muscle Warfare see them at their website: http://musclewarfare.com/home/
About Vitamin Shoppe, Inc. (VSI)
Vitamin Shoppe is a leading multi-channel specialty retailer of nutritional products based in North Bergen, New Jersey. In its stores and on its website, the company carries one of the most comprehensive retail assortments in the industry, including vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and health and beauty aids. In addition to offering 400 national brand products, the Vitamin Shoppe also exclusively carries products under The Vitamin Shoppe, BodyTech, True Athlete and MyTrition brands. The Vitamin Shoppe conducts business through more than 600 company-operated retail stores under The Vitamin Shoppe, Super Supplements and Vitapath retail banners, and through its website, www.VitaminShoppe.com. Follow The Vitamin Shoppe on Facebook at http://www.facebook.com/THEVITAMINSHOPPE
and on Twitter at http://twitter.com/VitaminShoppe
About Embark Holdings, Inc. (OTC: EMBK)
Founded in 1985 and headquartered in Mission Viejo, California, United States, our business model is to research, evaluate, and acquire profitable private firms in the business segments of entertainment, technology, medical, energy, and business services for the benefit of our shareholders.
By providing the financial and human capital necessary to deal with the overwhelming administrative, planning, governance, compliance, and regulatory issues that abound, our partners can focus their energy and flourish.
Stay up-to-date with current events by joining Embark Holdings, Inc. E-Mail Alert List. Join by going to the following: email@example.com
FORWARD-LOOKING STATEMENT: This press release contains forward-looking statements, including expected industry patterns and other financial and business results that involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: the sustainability of recent growth rates in the holding industry; the positioning of Embark Holdings in the market; ability to integrate acquired companies and technology; ability to retain key employees; ability to successfully combine product offerings and customer acceptance of combined products; general market conditions, fluctuations in currency exchange rates, changes to operating systems and product strategy by vendors of operating systems; and whether Embark Holdings can successfully gain market acceptance. Actual results may differ materially from those contained in the forward-looking statements in this press release.
Investor Contact Information:
Freebird Capital, Inc.
Phone: (888) 862-1409
SOURCE: Embark Holdings, Inc.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed for Embark Holdings, Inc. (OTC:EMBK), FNMG was compensated one thousand dollars for coverage of this news releases. FNMG HOLDS NO SHARES OF Embark Holdings, Inc. (OTC:EMBK).
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.